Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ACORN starts Phase IIb breast cancer trial with Bayer and Onyx
The trial will enroll a total of 220 patients at approximately 45 sites in approximately 20 states and will assess efficacy, safety and patient quality of life as
The trial will enroll a total of 220 patients at approximately 45 sites in approximately 20 states and will assess efficacy, safety and patient quality of life as
Amrix had similar efficacy to cyclobenzaprine immediate-release (CIR) taken three times a day in alleviating acute muscle spasm associated with lower back and neck pain. In addition, less
David Scopes, chief scientific officer of Senexis, said: “We believe our collaboration with O2H leverages the complementary expertise of both organisations and will benefit our search for new
The company and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,667 shares, respectively, at the initial
The agreement mainly focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a
The first patent claims a layered immediate-release (IR) tablet having at least two different active ingredients segregated from each other by a drug-free layer. The innovative tablet design
The primary endpoint of the study is to evaluate the safety and effectiveness of lixivaptan, when compared to placebo, in increasing serum sodium from baseline in heart failure
The European Medicines Agency (EMEA) orphan drug designation program is dedicated to stimulate and support the development of pharmaceuticals to treat life-threatening or very serious and rare diseases,
The report includes a list of 40 individuals convicted of crimes between fiscal years 2003 and 2005 who it maintains the FDA should have debarred. Overall, the report
Venture Investors of Madison, Wisconsin, with participation by Black Mountain Ventures of Foster City, California, led the investment. The company will use the funding to refine product development